Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial ...
BioMed Reports,
Encouraging data from phase I study published in Cancer Chemotherapy and Pharmacology LONDON--( BUSINESS WIRE )-- Tiziana Life…
Tiziana gains on milciclib cancer data
BioCentury,
Tiziana Life Sciences plc (LSE:TILS) jumped 30.50p (16%) to 219p on Friday after announcing data from a Phase I trial of…
Tiziana gains on milciclib cancer data
BioCentury,
Tiziana Life Sciences plc (LSE:TILS) jumped 30.50p (16%) to 219p on Friday after announcing data from a Phase I trial of…
Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours
Benzinga,
Tiziana Life Sciences plc (AIM:TILS, the "Company"), a clinical stage biotechnology company developing targeted drugs for…
Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours
Business Wire,
LONDON--( BUSINESS WIRE )--Tiziana Life Sciences plc (AIM:TILS, the "Company"), a clinical stage biotechnology company…
Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours - Press Release
Digital Journal,
LONDON--(Business Wire)--Tiziana Life Sciences plc (AIM:TILS, the "Company"), a clinical stage biotechnology company developing…
Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib …
Yahoo! Finance USA,
LONDON--(BUSINESS WIRE)--Tiziana Life Sciences plc (AIM:TILS, the "Company"), a clinical stage biotechnology company developing…
Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours
Bioportfolio,
Encouraging data from phase I study published in Cancer Chemotherapy and Pharmacology Tiziana Life Sciences plc (AIM:TILS, the "C…
News story from Finanz Nachrichten on Friday 21 April 2017
Finanz Nachrichten,
Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours
NASDAQ,
Encouraging data from phase I study published in Cancer Chemotherapy and Pharmacology LONDON--(BUSINESS WIRE)-- Tiziana Life…
Tiziana Life Sciences Plc Announces Publication Of Peer-Reviewed Paper From Positive Clinical Trial Of Milciclib In Patients With Refractory Solid Tumours
Biospace,
Encouraging data from phase I study published in Cancer Chemotherapy and Pharmacology LONDON--( BUSINESS WIRE )--Tiziana Life…